In the present study using a murine model, we demonstrated the potential of a new therapeutic approach for markedly reducing the progression of organ-specific autoimmune diseases through the efficient accumulation of chemokine receptor-expressing CD4+CD25+ regulatory T cells in target organs. Here, CD4 is linked to autoimmune disease.